Not all head-to-head trials are created equal: Results from an open-label, short-term study seem inconsistent with previous donepezil literature (multiple letters) [2]

International Journal of Geriatric Psychiatry

Volumn 20, Issue 1, 2005, Pages 85-87

  Bullock, Roger ^a   Truyen, Luc ^b   Jones, Roy ^c   Soininen, Hilkka ^d   Hager, Klaus ^e   Aarsland, Dag ^f   Passmore, Peter ^g  

^a VICTORIA HOSPITAL   (United Kingdom)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c St Martins Hospital   (United Kingdom)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e Dept of Med Rehab/Griatrics ^*  (Germany)

^f STAVANGER UNIVERSITY HOSPITAL   (Norway)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE;

ALZHEIMER DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESEARCH; DRUG RESPONSE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 11844286957     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1233     Document Type: Letter

References (0)